ELSA Wave 9 Biomarker Collection
Lead Research Organisation:
University College London
Department Name: Epidemiology and Public Health
Organisations
People |
ORCID iD |
Andrew Steptoe (Principal Investigator) |
Publications
RamÃrez PC
(2023)
Is dynapenic abdominal obesity a risk factor for cardiovascular mortality? A competing risk analysis.
in Age and ageing
Ajnakina O
(2021)
Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large population-based cohort study and external validation.
in BMC medical research methodology
Ma Y
(2021)
Different hypertension thresholds and cognitive decline: a pooled analysis of three ageing cohorts.
in BMC medicine
Gorry D
(2021)
The effect of retirement on health biomarkers.
in Economics and human biology
Duffner LA
(2022)
The role of cognitive and social leisure activities in dementia risk: assessing longitudinal associations of modifiable and non-modifiable risk factors.
in Epidemiology and psychiatric sciences
Sutin AR
(2022)
Sense of Purpose in Life and Markers of Hearing Function: Replicated Associations across Two Longitudinal Cohorts.
in Gerontology
Loeffler A
(2021)
Bidirectional longitudinal associations between loneliness and pain, and the role of inflammation.
in Pain
Adam CT
(2021)
Are elevated plasma fibrinogen associated with lung function? An 8-year follow-up of the ELSA study.
in PloS one
Description | It is difficult to pinpoint key findings yet, because these will depend on the ways in which the data are used by researchers in the UK and other countries in the future. Some publications have already appeared, but may more are likely over the next few years. |
Exploitation Route | Now the data are available, they can be analysed by scientists and policy makers registered with the UK Data Service |
Sectors | Environment,Healthcare |
Description | The biomarkers collected in wave 9 of ELSA (2018/2019) are now being used in scientific publications, as well as some policy events. They contribute to better understanding of the links between social factors, behaviour, biology, and health. A particularly valuable aspect has been providing the ability to understand how biological factors might contribute to emotional responses during the COVID-19 pandemic. This theme is likely to be extended in future analyses. Because the biomarker data are made available through the UKDS, we do not know of all the ways in which they are being used by researchers in the UK and other countries. They may be used in novel ways in the future by investigators from multiple disciplines. |
First Year Of Impact | 2020 |
Sector | Healthcare |
Impact Types | Societal |